Soley Therapeutics

Soley Therapeutics is a science-first, tech-enabled drug discovery and development company headquartered in South San Francisco, California, using human cells as biological sensors to uncover first-in-class medicines. Its cell stress sensing platform captures time-resolved cellular responses across thousands of features and applies computer vision and machine learning to compress them into compact signatures, screening hundreds of thousands of compounds per week on proprietary automation and robotics. The company is advancing a lead oncology asset for acute myeloid leukemia toward an IND filing, a second oncology asset for solid tumors in IND-enabling studies, and non-oncology stress-reducing candidates for neurodegenerative and metabolic disease. Soley raised a $200M Series C in January 2026, bringing total funding to roughly $290M. The platform is an internal discovery engine: Soley is a therapeutics developer, not a software vendor, and publishes no public API, developer portal, or machine-readable specification.

Soley Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Drug Discovery, and Oncology.

🌐 Visit website 📡 Source on GitHub
5.6/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyTherapeuticsDrug DiscoveryOncologyArtificial IntelligenceMachine LearningLife SciencesHealth Care

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 5.6/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 0.0 / 17
Operational Transparency 0.6 / 11
Governance 0.0 / 10
Discoverability 3.9 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/soley-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Soley Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization
GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact
Contact

Company 2

The organization behind the API

Website
Website
 About
About

Other 2

Properties that don't map to a standard resource type

Pipeline
Pipeline
 SecondaryMarket
SecondaryMarket

Source (apis.yml)

apis.yml Raw ↑ 
aid: soley-therapeutics
name: Soley Therapeutics
description: 'Soley Therapeutics is a science-first, tech-enabled drug discovery and development company headquartered in
  South San Francisco, California, using human cells as biological sensors to uncover first-in-class medicines. Its cell stress
  sensing platform captures time-resolved cellular responses across thousands of features and applies computer vision and
  machine learning to compress them into compact signatures, screening hundreds of thousands of compounds per week on proprietary
  automation and robotics. The company is advancing a lead oncology asset for acute myeloid leukemia toward an IND filing,
  a second oncology asset for solid tumors in IND-enabling studies, and non-oncology stress-reducing candidates for neurodegenerative
  and metabolic disease. Soley raised a $200M Series C in January 2026, bringing total funding to roughly $290M. The platform
  is an internal discovery engine: Soley is a therapeutics developer, not a software vendor, and publishes no public API,
  developer portal, or machine-readable specification.'
url: https://raw.githubusercontent.com/api-evangelist/soley-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Therapeutics
- Drug Discovery
- Oncology
- Artificial Intelligence
- Machine Learning
- Life Sciences
- Health Care
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/soley-therapeutics-domain-security.yml
- type: Website
  url: https://soleytherapeutics.com/
- type: About
  url: https://soleytherapeutics.com/about/
- type: Pipeline
  url: https://soleytherapeutics.com/pipeline/
- type: Contact
  url: https://soleytherapeutics.com/contact/
- type: GitHubOrganization
  url: https://github.com/Soley-Therapeutics
- type: SecondaryMarket
  url: https://www.hiive.com/securities/soley-therapeutics-stock
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: 'Soley sells therapeutics, not software - its cell stress sensing platform is an internal discovery engine - and
    no API host exists to document: wildcard DNS makes api/docs/developer subdomains resolve to the same WordPress marketing
    host whose TLS certificate covers only the apex and www, the GitHub org holds only two forks of third-party ML infrastructure
    (NVIDIA dcgm-exporter), and no npm or PyPI package exists. Note the 202s below are a SiteGround "sg-captcha: challenge"
    interstitial that answers every path including a nonsense control, so the marketing site itself was never readable by
    our probe - the no-API finding rests on the DNS, TLS, GitHub and registry evidence, not on that host.'
  evidence:
  - url: https://github.com/Soley-Therapeutics
    status: 200
  - url: https://api.github.com/orgs/soley-therapeutics/repos
    status: 200
  - url: https://registry.npmjs.org/-/v1/search?text=soley%20therapeutics
    status: 200
  - url: https://pypi.org/pypi/soley-therapeutics/json
    status: 404
  - url: https://soleytherapeutics.com/.well-known/agent-card.json
    status: 202
  - url: https://soleytherapeutics.com/openapi.json
    status: 202
  checked: '2026-08-05'